• About us
• Contact

Advertisement

Organisation › Details

Wacker Biotech GmbH

Wacker Biotech GmbH, Wacker Biotech B.V. and Wacker Biotech US Inc. are full-service contract manufacturers of therapeutic proteins, live microbial products (LMPs), plasmid DNA (pDNA), messenger ribonucleic acid (mRNA) and vaccines based on microbial systems. Wacker Biotech’s portfolio extends from strain/process development and analytical testing through to production for clinical and commercial applications. Wacker Biotech operates three GMP-compliant (Good Manufacturing Practice), FDA- and EMA-certified production plants at its Jena and Halle sites in Germany and in Amsterdam in the Netherlands. In addition, Wacker Biotech has had a plant in San Diego (Wacker Biotech US Inc.) since February 2021. Wacker Biotech GmbH, Wacker Biotech B.V. and Wacker Biotech US Inc. are wholly owned subsidiaries of Munich-based Wacker Chemie AG. *

 

	Start	2005-01-01 renamed
	Group	Wacker (Group)
	Predecessor	ProThera GmbH
	Person	Maier, Thomas (Wacker Biotech 200511)
	Region	Jena
	Country	Germany
	Street	3 Hans-Knöll-Str.
	City	07745 Jena
	Tel	+49-3641-5348-0
		Address record changed: 2022-10-02
Basic data	Employees	n. a.
		* Document for »About Section«: Wacker Chemie AG. (7/5/22). "Press Release: Wacker to Start Construction of Competence Center for mRNA Actives at Halle Site". Tübingen & Boston, MA.
		Record changed: 2023-12-30

Advertisement

More documents for Wacker (Group)

• [1] Pantherna Therapeutics GmbH / Wacker. (4/5/24). "Press Release: Pantherna and Wacker Intensify Collaboration in the Development and Production of mRNA Biopharmaceuticals". Munich & Hennigsdorf....
• [2] Wacker Chemie AG. (5/8/23). "Press Release: Wacker Purchases ADL BioPharma in Spain, Strengthening Its Biotechnology Business". Munich & León....
• [3] Wacker Chemie AG. (10/12/22). "Press Release: Neuway Pharma and Wacker Launch Research Project to Develop RNA-Based Actives for the Treatment of Central Nervous System Diseases". Munich & Bonn....
• [4] Wacker Chemie AG. (7/5/22). "Press Release: Wacker to Start Construction of Competence Center for mRNA Actives at Halle Site". Tübingen & Boston, MA....
• [5] Wacker Chemie AG. (6/2/22). "Press Release: Wacker to Invest Double-Digit Million-Euro Sum in Biotechnology Center". Munich....
• [6] mk2 Biotechnologies GmbH. (6/7/22). "Press Release: mk2 Biotechnologies, Wacker and TUM Jointly Develop a Process for the Large-scale Production of Antimicrobial Peptides Based on Sustainable Fermentation"....
• [7] Wacker Chemie AG. (1/17/22). "Press Release: Plasmitec – Wacker Introduces Its Plasmid DNA Production Platform". Munich & San Diego, CA....
• [8] Wacker Chemie AG. (1/11/22). "Press Release: Wacker and Biosyntia Develop Large-Scale Production Process for Sustainable Biotin". Munich & Copenhagen....
• [9] Wacker Chemie AG. (12/14/21). "Press Release: Wacker and CordenPharma Develop Solutions for Formulating Lipid Nanoparticles Expanding Their Portfolio for Advanced Medicines". Munich & Luxembourg....
• [10] Wacker Chemie AG. (12/8/21). "Press Release: Aleph Farms and Wacker Develop Open Supply Chain Solution for Proteins Used in Large-Scale Production of Cultivated Meat". Munich & Rehovot....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.